comprehensive -WSS

comprehensive

author：explore 2025-09-28 01:36:09 - browse：76717

An exercise physiologist works with a patient at a cardiac rehab class — Medicare plans to pay more for a type of cardiac rehabilitation that takes place in certain outpatient clinics owned by hospitals, going against growing support for site-neutral payments. Photo illustration: STAT, Photo: Mark Duncan/AP

Medicare plans to pay more for a type of cardiac rehabilitation that takes place in certain outpatient clinics owned by hospitals.

Medicare has admitted it is doing so due to an error in reading federal law, but it also goes against the grain of the current environment, where support for site-neutral payments has never been higher. Some members of Congress and health care experts are pushing for a system that would not pay hospital outpatient departments more for identical services that are provided in lower-priced physician offices.

Naturally, hospitals cheered regulators for increasing payments. But they don’t want the government to stop there. They also want Medicare to retroactively reprocess all underpaid heart rehab sessions, and they are using this proposal as a way to reiterate their desire to kill all policies that would pay hospital-owned clinics the same as physician offices.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Oprah kicked off a national conversation on obesity. Let's have it

WSS

Amid AI frenzy, a top HHS official's quest to create safeguards

Change Healthcare outage fallout shows need for new oversight

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Roche subsidiary Foundation Medicine opens new headquarters

Why depression after traumatic brain injury is distinct

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

leisure time

comprehensive

focus

Tori Bowie and the unacceptable rates of Black maternal death

Why the world’s most expensive drug might be worth the price

Tori Bowie and the unacceptable rates of Black maternal death

First U.S. drug developed to treat liver disease MASH is approved

Medical records are filled with copy

Washington mulls new rules to avert another Change Healthcare

Psychedelics group wrestles with new pharma identity

Why scientists need input from humanists on sensitive research

The high cost of giving birth even with insurance

Washington mulls new rules to avert another Change Healthcare

focus

Medicare coverage of Wegovy, once blocked, now looks possible

Readout LOUD podcast: mifepristone case, GLP

The Readout: Lenmeldy, GLP

HHS secretary Becerra pressed on Change HealthCare cyberattack

Male and female sex labels in research insufficient, scientists say

President Biden's budget: Here's what you might have missed

entertainment

focus

leisure time

focus